EQS-Adhoc: Evotec announces CEO transition
|
EQS-Ad-hoc: Evotec SE / Key word(s): Miscellaneous
Evotec announces CEO transition
03-Jan-2024 / 18:24 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
Hamburg, Germany, – Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, Prime Standard, ISIN: DE 000 566480 9, WKN 566480; NASDAQ: EVO) announces that CEO Dr Werner Lanthaler has informed the company, that he has decided to step down as CEO and will not continue to serve until the end of his current term, for personal reasons. The Supervisory Board has accepted his resignation from his office.
Werner Lanthaler will continue to be available as a strategic advisor to the company’s Supervisory Board. Dr Mario Polywka, former COO and currently member of the Supervisory Board has agreed to step in as interim CEO.
Evotec confirms guidance 2023.
– End of the ad hoc release –
Contact: Volker Braun, EVP Head of Global Investor Relations & ESG, Evotec SE, Manfred Eigen Campus, Essener Bogen 7, 22419 Hamburg, Germany, Phone: +49(0)151 19405058, [email protected]
End of Inside Information
03-Jan-2024 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com
|
| Language: |
English |
| Company: |
Evotec SE |
|
Manfred Eigen Campus / Essener Bogen 7 |
|
22419 Hamburg |
|
Germany |
| Phone: |
+49 (0)40 560 81-0 |
| Fax: |
+49 (0)40 560 81-222 |
| E-mail: |
[email protected] |
| Internet: |
www.evotec.com |
| ISIN: |
DE0005664809 |
| WKN: |
566480 |
| Indices: |
MDAX, TecDAX |
| Listed: |
Regulated Market in Berlin, Frankfurt (Prime Standard); Regulated Unofficial Market in Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange; Nasdaq |
| EQS News ID: |
1807841 |
| |
| End of Announcement |
EQS News Service |
1807841 03-Jan-2024 CET/CEST
|
Die wichtigsten Finanzdaten auf einen Blick
|
| |
2017 |
2018 |
2019 |
2020 |
2021 |
2022 |
2023e |
| Umsatzerlöse1 |
257,63 |
375,41 |
446,44 |
500,92 |
618,03 |
751,45 |
781,43 |
| EBITDA1,2 |
57,22 |
95,46 |
123,14 |
51,77 |
101,65 |
102,51 |
66,35 |
| EBITDA-Marge3 |
22,21 |
25,43 |
27,58 |
10,33 |
16,45 |
13,64 |
|
| EBIT1,4 |
37,50 |
77,46 |
62,59 |
48,52 |
41,00 |
20,85 |
-47,51 |
| EBIT-Marge5 |
14,56 |
20,63 |
14,02 |
9,69 |
6,63 |
2,78 |
-6,08 |
| Jahresüberschuss1 |
24,00 |
84,06 |
37,23 |
6,25 |
215,51 |
-175,66 |
-83,91 |
| Netto-Marge6 |
9,32 |
22,39 |
8,34 |
1,25 |
34,87 |
-23,38 |
-10,74 |
| Cashflow1,7 |
10,83 |
156,24 |
42,22 |
44,72 |
122,24 |
203,11 |
36,44 |
| Ergebnis je Aktie8 |
0,16 |
0,46 |
0,25 |
0,04 |
1,30 |
-0,99 |
-0,47 |
| Dividende8 |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
Quelle: boersengefluester.de und Firmenangaben
Geschäftsbericht 2023 - Kostenfrei herunterladen. 
1 in Mio. Euro; 2 EBITDA = Ergebnis vor Zinsen, Steuern und Abschreibungen; 3 EBITDA in Relation zum Umsatz; 4 EBIT = Ergebnis vor Zinsen und Steuern; 5 EBIT in Relation zum Umsatz; 6 Jahresüberschuss (-fehlbetrag) in Relation zum Umsatz; 7 Cashflow aus der gewöhnlichen Geschäftstätigkeit; 8 in Euro; Quelle: boersengefluester.de
Wirtschaftsprüfer: BDO
|
| INVESTOR-INFORMATIONEN |
| ©boersengefluester.de |
| Evotec |
| WKN |
Kurs in € |
Einschätzung |
Börsenwert in Mio. € |
| 566480 |
9,235 |
Halten |
1.639,60 |
| KGV 2025e |
KGV 10Y-Ø |
BGFL-Ratio |
Shiller-KGV |
| 17,42 |
35,60 |
0,49 |
79,61 |
| KBV |
KCV |
KUV |
EV/EBITDA |
| 1,46 |
45,00 |
2,10 |
25,04 |
| Dividende '22 in € |
Dividende '23e in € |
Div.-Rendite '23e
in % |
Hauptversammlung |
| 0,00 |
0,00 |
0,00 |
10.06.2024 |
| Q1-Zahlen |
Q2-Zahlen |
Q3-Zahlen |
Bilanz-PK |
| 22.05.2024 |
14.08.2024 |
06.11.2024 |
24.04.2024 |
| Abstand 60Tage-Linie |
Abstand 200Tage-Linie |
Performance YtD |
Performance 52 Wochen |
| -31,24% |
-47,29% |
-56,60% |
-44,45% |
|
|
Evotec SE DE0005664809